The Anglophone Africa Civil Society and Communities CCM Shadow Report and Scorecard Initiative
People Who Inject Drugs
In addition, the following individuals of our external expert advisory committee made instrumental contributions to the initial design and content of the document: Billy Pick, USAID; Daniel Wolfe, Open Society Foundations; Dave Burrows, AIDS Projects Management Group; Fabi...enne Hariga, United Nations Office on Drugs and Crime; Mauro Guarinieri, the Global Fund to Fight AIDS, Tuberculosis and Malaria; Richard Needle, Office of the U.S. Global AIDS Coordinator; and Sergey Votyagov, EHRN.
more
Research Article
Hindawi Publishing Corporation
AIDS Research and Treatment
Volume 2011, Article ID 621078, 7 pages doi:10.1155/2011/621078
Osoianu and Halacu BMC Infectious Diseases 2014, 14(Suppl 4):P8 http://www.biomedcentral.com/1471-2334/14/S4/P8
From The 7th Romanian National HIV/AIDS Congress and The 2nd Central European HIV Forum Sibiu, Romania. 29-31 May 2014
Some 90 per cent of Yemen’s food has to be imported and since a Saudi-led coalition imposed a blockade of the country’s key northern ports more than a month ago, only over a third of the food its people need is coming in.
More than 7 million people are now at acute risk of famine
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
This research report provides results from the study on living conditions among people with disabilities in Zambia. Comparisons are made between individuals with and without disabilities and also between households with and without a disabled family member. Results obtained in Zambia are also compar...ed to those obtained in earlier studies carried out in Namibia, Zimbabwe and Malawi. The Zambian study was undertaken in 2005-2006.
more
The WHO Global Burden of Disease (GBD) study measures the burden of
disease using the disability-adjusted life year metric (DALY). The DALY metric
was developed to assess the burden of disease consistently across diseases,
risk factors and regions. A consistent and comparative description of the ...burden
of diseases and injuries and the risk factors that cause them is important as it
can inform health decision-making and health care planning.
more
Eastern Europe and Eurasia: A Comparative Report
Accessed: 29.09.2019
Public Health Factsheet
Accessed: 29.09.2019
2014
Addendum to meeting report: Regional consultation on HIV epidemiologic information in Latin America and the Caribbean
Брифинг | 16 марта 2020
Принципы «не навреди», прозрачности, равенства, человечности: ценности, которыми должен руководствоваться сектор уголовного правосудия в борь...бе с коронавирусом
На момент публикации было зарегистрировано более 164 000 * подтвержденных случаев COVID-19, новой формы коронавируса, в 110 странах с более чем 6 470 со смертельным исходом. В этом брифинге мы оцениваем текущую ситуацию со вспышками COVID-19 и меры по предотвращению их появления в тюрьмах ** и более широкое оказание мер со стороны правительства людям, находящимся в системе уголовного правосудия. Настоящим документом выражается призыв к действиям, которые необходимо предпринять незамедлительно, учитывая риски, которым подвергаются люди, находящиеся в тюрьмах, включая непосредственно сам тюремный персонал.
more
COVID-19 и права меньшинств: обзор и перспективные практики
COVID-19 and minority rights: overview and perspective practices
Internews and Maharat collected and analyzed 433 rumors about COVID-19 circulating on social media
between January 5, 2021and January 31, 2021. This bulletin highlights community perceptions and criticisms about different topics
Le présent plan prend la suite de deux plans nationaux pour préserver l’efficacité des antibiotiques (2001-2005 et 2007-2010), qui visaient à maîtriser et rationaliser la prescription des antibiotiques. Ce troisième plan a pour titre « plan national 2011-2016 d’alerte sur les antibiotique...s ». Derrière ce titre se profile une menace de santé publique majeure : un nombre croissant de situations d’impasse thérapeutique contre des infections bactériennes, du fait du développement des résistances aux antibiotiques. Cette menace appelle une mobilisation déterminée et durable de l’ensemble des acteurs impliqués dans le cycle de vie des antibiotiques, afin de concilier des objectifs individuels (qualité de la prise en charge des patients) et collectifs (préservation d’une ressource rare, précieuse et difficile à renouveler).
more